LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Kodu・Aktsiate loetelu・Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc

Suletud

SektorTervishoid

94.04 0.74

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

90.62

Max

94.1

Põhinäitajad
By Trading Economics
Sissetulek	-92M 139M
Müük	242M 2.2B
P/E Sektori keskmine	28.025 66.845
Aktsiakasum	2.42
Dividenditootlus	0.98
Kasumimarginaal	6.213
Töötajad	17,000
EBITDA	-184M 454M

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+8.14% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	0.98% 2.25%
Järgmine tulemuste avaldamine	4. mai 2026
Järgmine dividendimakse kuupäev	30. apr 2026
Järgmine aktsia dividendi kuupäev (ex-date)	31. märts 2026

Turustatistika
By TradingEconomics
Turukapital	1.9B 20B
Eelmine avamishind	93.3
Eelmine sulgemishind	94.04

Uudiste sentiment

By Acuity

11%

89%

14 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

92.27 / 100.88 Toetus ja vastupanu

Zimmer Biomet Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. nov 2025, 19:38 UTC

Tulu

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5. nov 2025, 17:00 UTC

Tulu

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Zimmer Biomet Holdings Inc Prognoos

Hinnasiht

By TipRanks

8.14% tõus

12 kuu keskmine prognoos

Keskmine 101.06 USD 8.14%

Kõrge 120 USD

Madal 88 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Zimmer Biomet Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

20 ratings

Osta

Hoia

Müü

Põhineb 20 analüütiku instrumendi Zimmer Biomet Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

92.27 / 100.88Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

14 / 351 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.